Results 331 to 340 of about 10,935,890 (352)
Some of the next articles are maybe not open access.
Metastasis of Cancer to Cancer
The Thoracic and Cardiovascular Surgeon, 1986Metastasis of cancer to cancer is exceedingly rare, the most frequent being metastasis from bronchogenic carcinoma to renal carcinoma. A case of breast carcinoma metastasizing to a fibrosarcomatous malignant mesothelioma is presented. Breast carcinoma metastasizing to another carcinoma has been reported 4 times in the past.
Andersen Hj, Hansen Lg, Paulsen Sm
openaire +2 more sources
Cancer of the Breast, Cervical Cancers, Ovarian Cancers, and Other Cancers
1994A high-dose chemoradiotherapy (HDC) combined with hemopoietic stem cell transplantation (HSCT) has become an increasingly used modality for the treatment of patients with breast carcinoma.1 ...
Jean-Pierre Moquin, Jacques Lorrain
openaire +2 more sources
The microbiome, cancer, and cancer therapy
Nature Medicine, 2019With the advent of next-generation sequencing, we have an unprecedented ability to study tumor and host genomes as well as those of the vast array of microorganisms that exist within living organisms. Evidence now suggests that these microbes may confer susceptibility to certain cancers and may also influence response to therapeutics.
Jennifer A. Wargo +4 more
openaire +2 more sources
Current Opinion in Oncology, 1992
In the search for sensitive and specific tumor markers for bladder carcinoma, expression of various oncogenes and gene products (such as c-erb B-2, p53) and epidermal growth factor receptor merits particular attention. Although the results are not yet conclusive, important predictive markers are about to emerge from ongoing studies in this field ...
openaire +6 more sources
In the search for sensitive and specific tumor markers for bladder carcinoma, expression of various oncogenes and gene products (such as c-erb B-2, p53) and epidermal growth factor receptor merits particular attention. Although the results are not yet conclusive, important predictive markers are about to emerge from ongoing studies in this field ...
openaire +6 more sources
The Lancet, 1973
The idea that cigarette smoke causes lung cancer makes a strong intuitive appeal. We can readily envisage airborne carcinogens passing through the mouth, past the larynx and pharynx, down the trachea to the bronchi and lodging in the lungs. Animal experiments reveal chemical carcinogens in the condensate of cigarette smoke and no great imaginative feat
openaire +5 more sources
The idea that cigarette smoke causes lung cancer makes a strong intuitive appeal. We can readily envisage airborne carcinogens passing through the mouth, past the larynx and pharynx, down the trachea to the bronchi and lodging in the lungs. Animal experiments reveal chemical carcinogens in the condensate of cigarette smoke and no great imaginative feat
openaire +5 more sources
New England Journal of Medicine, 1975
HERE IS A SPECIAL HEALTH MESSAGE RED MAY MEAN DEAD FOR YOU OR YOUR LOVED ONES With scare tactics as blatantly callous as these a Sioux City, Iowa, firm is frightening shoppers into buying a product called "Homaganized Bakon" — exact composition unrevealed except that it contains no nitrites or nitrates.
openaire +2 more sources
HERE IS A SPECIAL HEALTH MESSAGE RED MAY MEAN DEAD FOR YOU OR YOUR LOVED ONES With scare tactics as blatantly callous as these a Sioux City, Iowa, firm is frightening shoppers into buying a product called "Homaganized Bakon" — exact composition unrevealed except that it contains no nitrites or nitrates.
openaire +2 more sources
Cancer chemotherapy and biological response modifiers, 1990
In small cell lung cancer (SCLC) combination chemotherapy including agents such as etoposide, teniposide, cisplatinum, carboplatin, and vincristine, doxorubicin, and cyclophosphamide, or ifosfamide continues to be the back-bone of therapy. The epipodophyllotoxin derivatives together with cisplatin or carboplatin are being used increasingly as part of ...
H H, Hansen, M, Rørth
openaire +10 more sources
In small cell lung cancer (SCLC) combination chemotherapy including agents such as etoposide, teniposide, cisplatinum, carboplatin, and vincristine, doxorubicin, and cyclophosphamide, or ifosfamide continues to be the back-bone of therapy. The epipodophyllotoxin derivatives together with cisplatin or carboplatin are being used increasingly as part of ...
H H, Hansen, M, Rørth
openaire +10 more sources
Metastasis of Cancer to Cancer
American Journal of Clinical Pathology, 1954S. M. Rabson +3 more
openaire +3 more sources